Injection Pen Market Future Outlook, Applications and Dynamics By 2023

 Global Injection Pen Market Research Report: By Type (Disposable Injection Pens, Others), by Product (Insulin Pens, Pen Needles), by Therapy (Diabetes, Others), by Distribution Channel (Hospital Pharmacies, Others), by End-User – Global Forecast Till 2023

Injection Pen Market Overview

Healthcare sector is already underway towards revolution with competition amid key players getting intense and growing aggression to develop devices that sync well with latest connected devices. Similarly, injection pen is one of the crucial innovations in the field of drug delivery. Market Research Future estimated that the global injection pen market would attain a CAGR of 6.5% during the forecast period 2017-2023.

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/6146

Manufacturers recognizing the importance of advanced drug delivery devices, increased investment in digital and healthcare analytics are some of the modern trends that might spur the growth of the global injection pen market. Consumers inclination on personalized and smart products has led to increased demand insights for injection pens. Rapid scaling and sophisticated service offering by the service providers have also helped to uphold the growth of the global market. Moreover, growing prevalence of chronic diseases such as osteoporosis and diabetes are anticipated to drive the global injection pen market. Changing lifestyle, unhygienic food consumption, and a growing number of patients who require daily dose of insulin are some of the factors that are of root disease outbreak, leading to increased numbers in patients.

Big technology players and venture capitalists are bringing high-tech product architectures that are creating lucrative opportunities for the healthcare industries.

Injection Pen Market Competitive players

Industry leaders are rapidly shifting from the beta test and experiments to full-fledged product building. These leading giants include the

• Novo Nordisk
• Ypsomed
• Sanofi
• Owen Mumford
• F. Hoffman-La Roche
• Jiangsu Delfu Medical Device Co. Ltd.
• Pfizer
• Becton Dickinson and Company
• Biocon Ltd.
• Haselmeier
• Merck
• AstraZeneca
• Eli Lilly
• Novartis

Injection Pen Market Segmentation

The rise in R&D activities in drug delivery is anticipated to play a major role in uplifting the growth graph of the global injection pen market during the forecast period.

The global injection pen market is broadly classified based on factors such as type, product, therapy, and end-user.

Based on type, the global injection pen market is bifurcated into disposable injection pens and reusable injection pens.

By product, the global market is segmented into pen needles and insulin pens.

Moreover, the global injection pen market is also segmented based on various therapies such as diabetes, fertility, growth hormone therapy, and osteoporosis.

The end-user segment is classified as home care, hospital, and clinics.

Injection Pen Market Regional Analysis

The Americas dominate the global injection pen market and are expected to maintain its influence during the forecast period. The leading position of the region in the global market is attributed to high adoption rate of injection pens and growing awareness of the drug delivery devices. Existence of leading market giants in Canada and the U.S. is encouraging the growth of the pen injection market in the region.

Following the Americas, Europe has a leading role in the global market, owing to burgeoning diabetics. Growing cases of diabetes have forced manufacturers to develop effective and convenient ways to handle the disease, as diabetes requires day-to-day administration of insulin injections. Thus, feasibility of self-managing the disease has boosted the demand for injection pen in region.

Moreover, the Asia Pacific is an emerging region with immensely growing population; the ratio of patient population with chronic is high. Rise in the figures of diabetics and increased healthcare expenditure has stimulated the growth of the global injection pen market.

The Middle East has the lowest share in the global injection pen market; however, upcoming healthcare investments led by some industrial players is expected to spur the growth rate of the regions.

Injection Pen Industrial updates

Biocorp, healthcare connected device maker has launched a cap for pen injectors that is internet-connected and transmit dosage information to a mobile app. The company stated that it is in talks with Sanofi’s diabetes care platform for negotiations. Its smart sensor cap, named Mallya is the only connected device with injections pens that is accessed to attain the accuracy requirements to achieve CE Class IIb classification by EU regulators. Earlier, in 2016, Companion Medical based in San-Deigo got FDA clearance for the wireless-enabled smart insulin pen, named Inpen.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

…Continued

Get More Information on Injection Pen Market Research Report – Forecast to 2023 @ https://www.marketresearchfuture.com/reports/injection-pen-market-6146

Brows More Healthcare Related Research Reports:

Biopsy Devices Market Applications, Size | Share and Trends, 2022

Population Health Management Market Size, Share, Growth, Industry Trends Analysis, Forecast 2023

Cosmetic Surgery Market Size, Growth and Share Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Telehealth Market Segmentation, SWOT Analysis and Dynamics

 Telehealth Market Research, Report 2020, Size, Share, Growth, Trends and Industry Analysis by Component (Hardware, Software and Services), by Mode of Delivery (Web/Cloud-Based and On-Premise), by Application (Radiology, Cardiology, Primary Care, Neurophysiology and others), by End User (Hospitals and Clinics, Diagnostic Centers, Home Care and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Global Forecast till 2024

Telehealth Market Overview:

Global telehealth market is on a path to score a CAGR of 22.74% and surpass a valuation of USD 16,173.8 Million by 2024. Market Research Future (MRFR) marks 2019 to 2024 as the forecast period. The telehealth sector is expected to thrive on the core concept it offers of sharing information using a digital platform to improve communication. It enables several functions like electronic consultations, video conferencing, remote monitoring, and wireless communications. Growing demand for easy access to various healthcare services, cost-effective and systematic procedure, hike in investment, better research & development facilities, improved IT sector, and others are factors that ensure growth for the market. But the possibility of information leakage through hacking can prevent the market from having easy growth.

Telehealth Market Competitive Analysis:

Telehealth market is witnessing a strong ingress of new entrants who are impacting the market with their latest innovations. This is also making the market competitive as established players are trying to capitalize on the opportunities available and increase their profit margin. MRFR listed a few to ensure a better understanding of the market and it includes companies like

• Siemens (Germany)
• Boston Scientific Corporation (US)
• AMD Global Telemedicine Inc. (US)
• Right Health (Canada)
• American Well (US)
• Allscripts Healthcare Solutions (US)
• Honeywell International Inc. (US)
• GlobalMed (US)
• Care Innovations LLC (US)
• Philips Healthcare (Netherlands)
• InTouch Technologies Inc. (US)
• Medtronic PLC (Ireland)
• Maple (Canada)
• Cisco Systems Inc. (US)
• Cerner Corporation (US)
• Dialogue (Canada)
• Livecare Health (Canada)

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/900

Telehealth Market Segmentation

Component, application, mode of delivery, and end user are four definite segments that have been discussed in the global market report on the telehealth sector. MRFR included these segments to provide better insights regarding various intricacies of the market.

Global Telehealth Market, by Component

• Services
  • Remote Monitoring
  • Real-Time Interactions
  • Store-and-Forward Consultations
• Hardware
  • Monitoring Devices
    • Stationary
    • Wearable
  • Medical Peripherals
    • Blood Pressure Monitors
    • ECG Monitors
    • Pulse Oximeters
    • Blood Glucose Meters
    • Peak Flow Meters
    • Otoscopes
    • Others
  • Others
• Software
  • Integrated Software
  • Standalone Software

Global Telehealth Market, by Mode of Delivery

• Web/Cloud-Based
• On-Premise

Global Telehealth Market, by Application

• Radiology
• Cardiology
• Primary Care
• Neurophysiology
• Others

Telehealth Market Regional Analysis

Basic requirements and the advanced ones for the growth of the telehealth market are widely available in Europe and the Americas. Of these two regions, the Americas are all set to score big in the coming years as countries like the US and Canada are going to ensure that the market gains better profit. Improved IT sector, better investment plans, growing digitalization, huge budget expenditure, and others are several sectors that can make sure that the market gains better prospects. In Europe, this market would benefit from the growing demand to monitor the steps of healthcare procedures. Italy has emerged as one of the leading countries by having control over almost 12.4% of the Western telehealth market in 2018. France, Germany, and the UK can also make sure that their growth in the sector goes up considerably.

The Asia Pacific market has a massive population that can trigger growth for the telehealth market. Increasing the inclusion of technologies to support better growth for the telehealth market. For the Middle East & Africa, poor economy and lack of infrastructure can hold back the growth rate and deter permeation of the sector.

Browse Related Reports at:

Cold Pain Therapy Market Research Report – Forecast to 2023 | MRFR

Chronic Lymphocytic Leukemia Treatment Market Size and Share | Forecast to 2023

Global Coronary Stents Market Demand, Size, Share, Growth, Forecast to 2023 | MRFR

Controlled Release Drug Delivery Market Share, Trends, Size and Industry Forecast to 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Metabolomics Services Market SWOT Analysis, Demand and Emerging Trends

 Metabolomics Services Market Analysis

The metabolomics services market size is predicted to touch USD 16,291.0 million at a 7.77% CAGR between 2016-2025, reveals the new Market Research Future (MRFR) report. Metabolomics is a study of unique chemical processes that are inside the cells and involves metabolites. This collection of metabolites in its entirety in an organism, organ, tissue, or biological cell is known as metabolome. These are the final products of cellular processes. Metabolomics is widely used in personalized medicine, functional genomics, nutrigenomics, toxicology testing, drug discovery, metabolomics profiling services such as biomarker discovery, among others. 

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/8435

Numerous factors are adding to themetabolomics services market demand. Such factors, as revealed by the latest MRFR report, include increasing application in the biotechnological and life science industry, technological advances in instrumentation, and increasing incidence of diseases like cardiac diseases, neurological disorders, and cancer worldwide. Additional factors adding to themetabolomics services market share include the growing necessity for toxicology testing, burgeoning demand for personalized medicine, and rising biotech & pharmaceutical research and development expenditure.

On the contrary, strict government regulations/policies and high instrument cost are factors that may limit the metabolomics services market growth over the forecast period.

Metabolomics Services Market Segmentation

The Market Research Future Report provides an inclusive segmental analysis of the metabolomics services market based on application and product & service.

By product & service, the metabolomics services market is segmented into mass spectrometry, metabolomics bioinformatics services, and chromatography. Chromatography is a method used in the laboratory to separate a mixture. It is of four types- paper chromatography, thin-layer chromatography, gas chromatography, and liquid chromatography. Bioinformatic tools and services are needed to perform essential functions like database functionalities and statistical analyses. It also helps researchers to decide that metabolites that are most meaningful biologically. Mass spectrometry is an advanced method to determine a compound’s molecular weight. Of these, metabolomics bioinformatics services will lead the market over the forecast period for its tremendous progress that is predicted to grow further for the use of parameter estimation techniques and robust algorithms in life-science analysis and research.

By application, the metabolomics services market is segmented into food, agriculture, biomedical, and pharmaceutical.

Metabolomics Services Market Regional Analysis

By region, the global metabolomics services market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will spearhead the market over the forecast period for the increasing incidence of cardiovascular diseases and cancer.

The global metabolomics services market in Europe is predicted to hold the second-largest share over the forecast period for the constant innovations in medical devices to augment the quality of life, increasing healthcare expenditure, and the presence of several top medical device companies in the region.

The global metabolomics services market in the APAC region is predicted to grow at a quick pace over the forecast period. Factors adding to the global metabolomics services market growth in the region include entry of leading companies, especially in developing countries, increase in R&D centers, growing disposable income, rising number of research and development organizations, and emerging healthcare infrastructure.

The global metabolomics services market in the MEA is predicted to have a small share during the forecast period for lack of adequate healthcare infrastructure and low per capita income.

Metabolomics Services Market Key Players

Leading players profiled in the global metabolomics services market report include Shimadzu Corporation (Japan), Human Metabolome Technologies America Inc. (Japan), Metabolon, INC (US), Creative Proteomics (US), Biocrates Life Sciences AG (Austria), Thermo Fisher Scientific (US), TMIC (Canada), Bruker (US), Agilent Technologies, Inc. (US), and Waters (US).

Metabolomics Services Industry News

March 2020: Regenr8 has joined hands with Physician’s Lab of Boca Raton to develop the first-ever epigenetic analysis- Epigenetic Biomarker Profile for determining the impact on an individual’s environment on his/her unique gene function by using the advanced diagnostic capabilities of the Physicians Lab for identifying different metabolites created from the enzymatic and metabolic cellular processes of tested individuals. This advanced metabolomic diagnostics will offer assessments of sleep markers, key vitamin markers, neurotransmitter metabolites, and much more.

Get More Information on Vascular Closure Devices Market Report-Forecast to 2023 @ https://www.marketresearchfuture.com/reports/metabolomics-services-market-8435 

Browse Related Reports at:

Medical Marijuana Market Statistics | Global Industry Size, Growth, And Forecast To 2023

CAR T Cell Therapy Market Size, Share, & Trends Analysis | Forecast to 2025

Preimplantation Genetic Testing Market Services, Size, Technology and Forecast To 2025

Healthcare Artificial Intelligence (AI) Market Size, Global Report, Trends, Industry Analysis by 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Patient Registry Software Market Size, Share, Outlook and Challenges

 Global Patient Registry Software Market: Information by Type of Registry (Disease Registries, Health Service Registries, Product Registries and others), Functionality (Population Health Management (PHM), Patient Care Management, Health Information Exchange (HIE) and others), Deployment Model (On-Premise and Cloud), End-User (Hospitals and Clinics, Government Organizations & Research Centers and Others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2025

Patient Registry Software Market Synopsis

Patient registry software market 2020 is on track to obtain a CAGR of 11.08% from 2019 to 2025 (appraisal period), says Market Research Future (MRFR). MRFR adds that the global market size can touch USD 1,998.83 Million by 2025. We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.

Request Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6917

Key Drivers and Primary Challenges

EHR’s Rising Adoption Rate to be a Major Growth Booster

Increasing deployment of electronic health records/EHR across the healthcare industry remains a prime growth booster in the patient registry software market. Regulatory authorities across developed nations promote the use of EHR solutions in healthcare practices for facilitating efficient delivery of services. Strict regulations that require implementation of electronic patient records and the escalating focus on ensuring top patient care quality would foster the demand for patient registry software in the years to come. The need to streamline and organize the voluminous patient registry databases in healthcare also works in favor of the global market.

Surge in Drug Development for Rare Diseases to Induce Growth  

Patient registry software is also known for facilitating complex drug development, especially when it comes to rare disorders. Currently, in Europe, more than 700 rare disease registries are aiding the collection of historical patient records, sample size reduction and measurements, and more. The software also helps track the correct intake of certain drugs and its results, which is another feather in its cap pushing its demand. Increasing spending on clinical trials by several pharmaceutical and biotechnological firms could emerge as a significant opportunity in the future. Pharmaceutical and medical device vendors continue to benefit from the multiple patient registries pertaining to post-marketing surveillance of various devices and drugs.

Cloud-Based Solutions to Garner Significant Traction

Cloud based patient registry solutions are the fastest emerging segment in the market, since these offer innovative features like remote access and real-time tracking of data. Both private firms and government are increasingly going for cloud-based patient registry solutions instead of on-premise solutions. On the competitive front, the market is observing a number of vendors getting involved in several initiatives including mergers, new product launch, acquisitions and collaboration for higher penetration. A case in point, in November 2020, MyoKardia collaborated with PINNACLE/Veradigm and the American College of Cardiology to release its latest Patient Registry of Hypertrophic Cardiomyopathy. This patient registry software is expected to help MyoKardia in terms of post-marketing effectiveness and safety analysis of mavacamten, which is a therapeutic for treating HCM/obstructive hypertrophic cardiomyopathy.

Patient Registry Software Market Segmentation

Patient registry software industry has been dissected in terms of type of registry, functionality, deployment model and end-user.

The types of registry available in the worldwide market include product registries, health service registries, disease registries, and others.

Functionality-wise, the market segments are health information exchange (HIE), patient care management, population health management (PHM), and others.

The primary deployment models are on-premise as well as cloud.

Government organizations & research centers, hospitals and clinics, and others are the top market end-users listed in the MRFR report.

Patient Registry Software Market Regional Insight                                       

The primary markets for patient registry software are the Americas, Asia Pacific/APAC, MEA/Middle East & Africa and Europe.

The Americas to Most Likely Procure the Leading Position

The Americas can presumably take the lead in the global market over the next few years, considering the advances in the healthcare IT segment and the significant uptake of advanced EHRs. It is also observed that many of the renowned firms in the region are increasingly acquiring the smaller companies to solidify their market positions. Surge in government efforts to promote the use of patient registry software is also responsible for the market growth. With the aim to develop patient registry software that is more clinical research-friendly and interactive, vendors are focusing on technical innovations, which could be favorable for the regional market. A key trend among the players is the development of integrated software, which is not only cost-effective but also offers remote access to patient records.

APAC to Maintain Fastest Growth Pace in the Coming Years

APAC’s progress in the coming years is expected to be at the fastest pace, as the governments are taking up several initiatives to address the need for better patient care quality and reduced healthcare costs. The patient registry software’s strong demand in the region is also the result of the need to cut down medical errors, frequent hospital visits and diagnostics errors. This, combined with the rising cases of co-morbidity, and the substantial growth in the geriatric population segment, can foster revenue generation. Japan, South Korea, China, and India are some of the leading contenders in the APAC market; especially considering the rising adoption of cloud based patient registry solutions in these countries.

Patient Registry Software Market Eminent Vendors

IFA SYSTEMS, Open Text Corporation, Dacima Software Inc, Optum, Inc., LUMEDX, ArborMetrix, phamax, IBM, IQVIA, Evado Pty. Ltd, McKesson Corporation are among some of the most eminent market vendors.

Browse Complete 106 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at  https://www.marketresearchfuture.com/reports/patient-registry-software-market-6917

Browse Related Reports at:

Rabies Diagnostics Market Size, Share, Trends and Industry Forecast to 2023 

Epilepsy Market | Therapeutics, Size Growth and Forecast to 2023

Cancer Registry Software Market Type, Application | Global Industry Report – 2024

Autoinjectors Market Growth, Size, Share and Industry Analysis by 2024

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Migraine Drugs Market Investment Feasibility, Share, Demand

 Migraine Drugs Market Outlook

The global migraine drugs market is predicted to grow at a 5.9% CAGR between 2019-2025, states the new Market Research Future (MRFR) report Info graphs of “Migraine Drugs Market Research Report – Global Forecast till 2025”

Migraines, simply put, are severe, painful, and recurring headaches, which can be accompanied or preceded by sensory warning symptoms and other signs. Its causes are not yet known but triggers that may set of migraine include hormonal changes in women, emotional triggers such as stress, depression, anxiety, or excitement, physical causes such as poor posture, insufficient sleep, or tiredness, triggers in the diet such as caffeine and alcohol, dehydration and irregular mealtimes, taking medications such as contraceptive pills, sleeping pills, or hormone replacement therapy medications, and triggers in the environment such as bright lights, loud noise or flickering screens. Migraine is of two types- chronic and episodic.

Migraine Drugs Market Key Players:

Prominent players profiled in the migraine drugs Industry report include eNeura Inc., Eli Lilly and Company, Amgen Inc (US), Johnson & Johnson Services, Inc. (US), AstraZeneca Plc (UK), Teva Pharmaceutical Industries Ltd (Israel), Merck & Co., Inc. (US), GlaxoSmithKline Plc (UK), Pfizer Inc. (US), Alder Biopharmaceuticals, Inc. (US), and Allergan Plc (Ireland).

Request for a Free Sample@ https://www.marketresearchfuture.com/sample_request/8379

Various factors are propelling the migraine drugs market growth stated by the latest Market Research Future (MRFR) report, include a rising focus on development on migraine drugs, lifestyle changes, unhealthy food consumption, awareness programs undertaken by organizations on prevention as well as treatment of migraine, and high unmet needs.

Market Segmentation:

The MRFR report provides an all-inclusive segmental analysis of the migraine drugs market on the basis of drug class, treatment, end user, and type.

Based on type, the migraine drugs Industry is segmented into chronic and episodic migraine. Of these, the episodic migraine will have maximum share in the market over the forecast period.

Based on treatment, the migraine drugs Industry is segmented into neuromodulation, preventive, acute, and others. Of these, the acute segment will command the largest share in the market over the forecast period owing to its high prevalence and availability of several drugs to treat acute migraines.

Based on drug class, the migraine drugs Industry is segmented into triptans, anticonvulsants, tricyclics, angiotensin blockers, beta-blockers, and others. Of these, the triptans segment will lead the market over the forecast period for its high efficacy.

Based on end user, the migraine drugs Industry is segmented into research and academic institutes, hospitals and clinics, and others. Of these, hospitals and clinics will dominate the market over the forecast period for being primary treatment centers for patients.

LIST OF TABLES

TABLE 1 GLOBAL MIGRAINE DRUGS MARKET SYNOPSIS, 2019–2025

TABLE 2 GLOBAL MIGRAINE DRUGS MARKET ESTIMATES & FORECAST, 2019–2025 (USD MILLION)

TABLE 3 GLOBAL MIGRAINE DRUGS MARKET, BY TREATMENT TYPE, 2019–2025 (USD MILLION)

TABLE 4 GLOBAL MIGRAINE DRUGS MARKET, BY DRUG CLASS, 2019–2025 (USD MILLION)

TABLE 5 GLOBAL MIGRAINE DRUGS MARKET, BY END USER, 2019-2025 (USD MILLION)

TABLE 6 GLOBAL MIGRAINE DRUGS MARKET, BY REGION, 2019–2025 (USD MILLION)

Continued……

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL MIGRAINE DRUGS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL MIGRAINE DRUGS MARKET

FIGURE 4 GLOBAL MIGRAINE DRUGS MARKET SHARE, BY TREATMENT TYPE, 2018 (%)

FIGURE 5 GLOBAL MIGRAINE DRUGS MARKET SHARE, BY DRUG CLASS, 2018 (%)

FIGURE 6 GLOBAL MIGRAINE DRUGS MARKET SHARE, BY END USER, 2018(%)

FIGURE 7 GLOBAL MIGRAINE DRUGS MARKET SHARE, BY REGION, 2018 (%)

Continued…….

Browse Related Reports at:

Oxygen Therapy Equipment Market by Product, Portability, Applications and Global Forecast to 2023

Surgical Scalpel Market Overview, Size, Share, Analysis | Global Industry Forecast 2023

Opioids Market Global Overview, Industry size Analysis, Trends, Application with Forecast 2023

Live Cell Encapsulation Market Research Report – Forecast to 2023 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Patient Lift Slings Market Insights, Emerging Trends and Landscape

 The report encompasses the major developments within the Global Patient Lift Slings Market amidst the novel COVID-19 pandemic. The report offers a thorough understanding of the different aspects of the market that are likely to be feel the impact of the pandemic.

Patient Lift Slings Market Outlook

The global patient lift slings market size is expected to reach a valuation of USD 6.07 billion by 2025. It can exhibit a CAGR of 12.4% during the forecast period. The high risk of injuries to caregivers and support staff in hospitals during the transfer of patients is the primary driving force of the market. Increasing number of cases of paralysis, disabilities, and prevalence of arthritis can push the demand for patient slings. According to the American Association of Neurological Surgeons, close to 17,000 spinal cord injuries occur annually. The spike in this number will elicit the need for slings during the forecast period.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/8374

Patient lift slings are patient assistance devices designed to assign patients with mobility issues to be transferred from their bed to continue with their daily activities. This can reduce injuries to the patient and medical staff. These devices have adjustable straps, fabric loops, and metal chains to ensure the safety of the patient. The global patient lift slings market report by Market Research Future (MRFR) has been compiled by taking in mind the numerous drivers, challenges, and opportunities for the period of 2019 to 2025 (forecast period).

Growing numbers of bariatric and geriatric patients can propel the global patient lift slings market growth. According to the National Center for Biotechnology Information in 2016, close to 5.4 million paralysis patients reside in the U.S. The implementation of policies to ensure the safety of healthcare workers can work in favor of the market.

Lack of training given to caregivers for operating slings can negatively impact the market growth.

Patient Lift Slings Market Segmentation

The global patient lift slings market has been segmented by product, sling shape, sling materials, usage, and end user.

By product, it is segmented into bathing & toileting slings, bariatric slings, stand up slings, seating slings, and others. Bariatric slings have the largest market share owing to their high demand by obese patients.

By sling shape, it is divided into full body sling and U-shape. The U-shape is predicted to dominate the Patient Lift Slings Market till 2025. This can be credited to the convenience provided to caregivers for carrying their patients to the restroom or being transferred to another room.

By sling materials, it is segmented into nylon, polyester, padded, mesh, and others. The nylon segment can generate revenues for the global patient lift slings market owing to being comfortable and long-lasting.

By usage, it is segmented into disposable and reusable. The reusable segment is pegged to grow at a rapid pace during the forecast period.

By end user, it is segmented into home care settings, hospitals, and others. Hospitals will be the biggest end users of patient lift slings due to these healthcare facilities catering to a large patient pool. Rise in surgeries and grievous injuries can support the growth of the segment.

Patient Lift Slings Market Regional Analysis

The market has been segmented, by region, into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas will sustain as the indomitable leader in the global patient lift slings market due to a large number of cases of cardiovascular diseases and diabetes. In this region, annually 795,000 people in the U.S. get strokes which can lead to paralysis. Europe, on the other hand, can register a strong growth rate during the forecast period owing to large numbers of lifestyle diseases, large geriatric population, and high recovery costs of injuries.

Patient Lift Slings Market Competitive Outlook

Arjo, Handicare, Prism Medical UK, Invacare, Joerns Healthcare, GF Health Products, Medline Industries, Guldmann, Hill-Rom Holdings, Inc., ETAC, and DJO Global are key players of the global patient lift slings market.

Browse Related Reports at:

ADME Toxicology Testing Market Size, Share, Trend, Growth, Industry Analysis – Global Forecast to 2023 | MRFR

Blood Collection Market Research Report – Forecast to 2023 | MRFR

Irritable Bowel Syndrome Treatment Market Analysis, Growth Values and Forecast to 2023

Voice Prosthesis Devices Market | Share, Technology and Forecast To 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Scoliosis Treatment Market Demand, Sales, Profit

 Scoliosis Treatment Market Analysis

The global scoliosis treatment market was valued USD 2,580.2 million in 2018 and is likely to grow at a 3.9% CAGR between 2019- 2025, as per the new report by Market Research Future (MRFR). Scoliosis, simply put, is an abnormal curve that happens in the spinal cord. Resting on how severe the curve is and its deteriorating risk, the scoliosis disease can be treated through surgery or with bracing. This disease has no cure, but the treatment can help to alleviate the pain.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/8230

Various factors are adding to the global scoliosis treatment market growth. Such factors, according to the new MRFR report, include cost-effective drugs, availability of scoliosis treatment, lack of exercise during puberty, which increases the risk of different spine disorders, rising cases of spine disorders, and increasing prevalence of scoliosis disease.

On the contrary, high treatment or procedure cost and little understanding about the disorders, as well as the treatment options available are factors that may limit the scoliosis treatment market growth over the forecast period. 

Scoliosis Treatment Market Segmentation 

The MRFR report offers an inclusive segmental analysis of the global scoliosis treatment market report based on the distribution channel, product, and disease.

By disease, the scoliosis treatment market is segmented into adolescent idiopathic scoliosis and infantile idiopathic scoliosis. Of these, the adolescent idiopathic scoliosis segment will lead the market over the forecast period.

By product, the scoliosis treatment market is segmented into lumbosacral orthosis (LSO), thoracolumbosacral orthosis (TLSO), and cervical thoracic lumbar sacral orthosis (CTLSO). Of these, the CTLSO segment will dominate the scoliosis treatment market during the forecast period for the growing demand for spine surgeries.

By distribution channel, the scoliosis treatment market is segmented into retail pharmacies, online pharmacies, and hospitals & clinics. Of these, hospitals & clinics will spearhead the market over the forecast period.

Scoliosis Treatment Market Regional Analysis

Based on the region, the scoliosis treatment market report covers the recent trends & growth opportunities across North America, Europe, the Asia Pacific (APAC), & the Middle East & Africa (MEA). Among these, North America is likely to lead the market over the forecast period. Factors boosting scoliosis treatment market growth in the region include the presence of leading key manufacturers, higher patient safety, maximum reimbursement coverage, and increasing awareness & programs held by key skilled and trained professionals. Besides, increasing use of branded support braces and rising surgical procedures are all adding to the market growth. The US & Canada are the chief contributors in the region for sophisticated healthcare infrastructure.

The scoliosis treatment market in Europe is likely to possess the second-largest share during the forecast period. Favorable reimbursement policies, high expenditure on R&D by government bodies, higher prevalence of the disease, increasing awareness among people, and sophisticated healthcare infrastructure are adding market growth.

The scoliosis treatment market in the Asia Pacific region is likely to develop at a high CAGR over the forecast period for rising awareness about the disorder and its treatment, increasing healthcare spending, availability of branded braces and supports, advanced healthcare settings, and surging population. Besides, product launches, constant technological advancements, and easy accessibility of management options are also adding market growth. Japan, China, India, Brazil, and Russia are the chief contributors in the region.

The scoliosis treatment market in Latin America and the MEA is predicted to have stagnant growth over the forecast period for the lack of awareness, low per capita healthcare expenditure, and scarcity of skilled personnel.

Browse Related Reports at:

Electric Wheelchair Market Growth Analysis, Size, Global Share and Industry Forecast to 2023

Bioprocess Containers Market | Technology, Trends and Growth Forecast To 2023

Keloid Treatment Market | Therapeutics, Size, Growth and Forecast To 2023

Controlled Release Drug Delivery Market Share, Trends, Size and Industry Forecast to 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.